Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hepatitis C virus.

Monica Jarrett1, Paula Cox

  • 1Hepatology Department, University of Washington, 1959 NE Pacific Street, Box 357266, Seattle, WA 98195-7266, USA. jarrett@u.washington.edu

The Nursing Clinics of North America
|April 6, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A Comprehensive Self-Management Program With Diet Education Does Not Alter Microbiome Characteristics in Women With Irritable Bowel Syndrome.

Biological research for nursing·2021
Same author

Sleep measures predict next-day symptoms in women with irritable bowel syndrome.

Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine·2014
Same author

Update on irritable bowel syndrome program of research.

Journal of Korean Academy of Nursing·2013
Same author

Don’t come up short.

Nursing management·2013
Same author

Urinary proteome analysis of irritable bowel syndrome (IBS) symptom subgroups.

Journal of proteome research·2012
Same author

Autonomic nervous system function in young children with functional abdominal pain or irritable bowel syndrome.

The journal of pain·2012

Hepatitis C virus (HCV) infections are declining, but long-term liver damage is emerging in previously infected individuals. Early identification and supervised treatment are crucial for managing advanced liver disease.

Area of Science:

  • Hepatology
  • Infectious Diseases
  • Public Health

Background:

  • Hepatitis C virus (HCV) is a prevalent blood-borne pathogen with declining new infections.
  • Individuals infected 2-3 decades ago are now presenting with significant liver damage.
  • HCV-related liver disease poses a growing clinical challenge.

Purpose of the Study:

  • To highlight the delayed onset of liver damage in chronic Hepatitis C virus patients.
  • To emphasize the importance of current treatment options and management strategies.
  • To advocate for improved identification and screening of at-risk populations.

Main Methods:

  • Review of existing literature on Hepatitis C virus epidemiology and long-term sequelae.
  • Analysis of treatment protocols involving interferon (IFN) and ribavirin.

Related Experiment Videos

  • Discussion of multidisciplinary care models involving nurses, physicians, and pharmacists.
  • Assessment of educational outreach strategies for public and healthcare provider awareness.

    • Main Results:

    • Chronic HCV infection leads to liver damage years after initial infection.
    • Interferon (IFN) and ribavirin treatment is effective but requires close monitoring due to adverse events.
    • Multidisciplinary supervision over 6-12 months is necessary for optimal patient outcomes.
    • Educational initiatives can improve early patient detection and screening.

    Conclusions:

    • Despite declining incidence, managing established liver damage from past Hepatitis C virus infections is critical.
    • Supervised, prolonged treatment regimens are essential for patients with advanced liver disease.
    • Enhanced public and provider education is vital for early identification and screening of high-risk groups to mitigate HCV complications.